Cipla’s subsidiary InvaGen’s manufacturing plant has received five inspectional observations in Form 483 from USFDA.
Technology to drive consolidation in broking and asset management: Saurabh Mukherjea
Saurabh Mukherjea of Marcellus Investment Managers anticipates profit margin compression in the AMC sector due to increased competition. He suggests potential US tariffs on India